Who Paid My Doc
Arthur Epstein
Optometrist, Corneal and Contact Management Phoenix, AZ Doctor of Optometry
NPI 1427038249 CMS profile 546032
3805 E Bell Rd, Ste 1800, Phoenix, AZ 85032
General payments
$278,992
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$244,197
Through program year 2022, Arthur Epstein of Phoenix, AZ is reported in the CMS Open Payments database as having received $278,992 across 327 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $244,197 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Optometrist, Corneal and Contact Management profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $12,271 | 27 | |
| 2021 | General | $44,396 | 61 | |
| 2020 | General | $125,510 | 88 | |
| 2019 | General | $96,815 | 151 |
Beside peers
- Arthur Epstein
- Optometrist, Corneal and Contact Management median
- Middle half of Optometrist, Corneal and Contact Management
- National median
In program year 2025, general payments to Arthur Epstein were reported at $0. Among 618 Optometrist, Corneal and Contact Management profiles paid that year, the median was $227 and the middle half received between $95 and $604.
Show as a table
| Year | Arthur Epstein | Optometrist, Corneal and Contact Management median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $96,815 | $203 | $84–$530 | $163 |
| 2020 | $125,510 | $88 | $35–$234 | $114 |
| 2021 | $44,396 | $143 | $54–$353 | $132 |
| 2022 | $12,271 | $167 | $65–$422 | $149 |
| 2023 | $0 | $195 | $76–$549 | $160 |
| 2024 | $0 | $202 | $85–$523 | $164 |
| 2025 | $0 | $227 | $95–$604 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
327 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Corneal and Contact Management in Arizona
Caitlin Morrison
Optometrist, Corneal and Contact Management · Scottsdale, AZ
Brianna Ryff
Optometrist, Corneal and Contact Management · Glendale, AZ
Nha Cao
Optometrist, Corneal and Contact Management · Scottsdale, AZ
David Anderson
Optometrist, Corneal and Contact Management · Phoenix, AZ
Erik Burnett
Optometrist, Corneal and Contact Management · Tucson, AZ
Bartholomew Pemberton
Optometrist, Corneal and Contact Management · Tucson, AZ
Related records
Optometrist, Corneal and Contact Management in Arizona
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Corneal and Contact Management
Everyone recorded under this specialty, nationwide.
Doctors in Arizona
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.